BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

638 related articles for article (PubMed ID: 31247468)

  • 21. Methanol extract of
    Ye X; Wu K; Xu L; Cen Y; Ni J; Chen J; Zheng W; Liu W
    Front Endocrinol (Lausanne); 2022; 13():1103972. PubMed ID: 36686454
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Research progress of Eubacterium and its metabolite short-chain fatty acids in regulating type 2 diabetes mellitus].
    Li WD; Li LS; Lyu MJ; Hu QY; Xiong DQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2023 Jan; 57(1):120-124. PubMed ID: 36655268
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Qualitative Parameters of the Colonic Flora in Patients with HNF1A-MODY Are Different from Those Observed in Type 2 Diabetes Mellitus.
    Mrozinska S; Radkowski P; Gosiewski T; Szopa M; Bulanda M; Ludwig-Galezowska AH; Morawska I; Sroka-Oleksiak A; Matejko B; Kapusta P; Salamon D; Malecki MT; Wolkow P; Klupa T
    J Diabetes Res; 2016; 2016():3876764. PubMed ID: 27807544
    [No Abstract]   [Full Text] [Related]  

  • 24. Gut microbiota and type 2 diabetes mellitus.
    Muñoz-Garach A; Diaz-Perdigones C; Tinahones FJ
    Endocrinol Nutr; 2016 Dec; 63(10):560-568. PubMed ID: 27633134
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interactive Relationships between Intestinal Flora and Bile Acids.
    Guo X; Okpara ES; Hu W; Yan C; Wang Y; Liang Q; Chiang JYL; Han S
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955473
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Altered Gut Microbiota in Type 2 Diabetes: Just a Coincidence?
    Sircana A; Framarin L; Leone N; Berrutti M; Castellino F; Parente R; De Michieli F; Paschetta E; Musso G
    Curr Diab Rep; 2018 Sep; 18(10):98. PubMed ID: 30215149
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fecal Microbiota Transplantation: Therapeutic Potential for a Multitude of Diseases beyond
    Bakker GJ; Nieuwdorp M
    Microbiol Spectr; 2017 Aug; 5(4):. PubMed ID: 28840809
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of intestinal microbiota in the pathogenesis of metabolic diseases.
    Węgielska I; Suliburska J
    Acta Sci Pol Technol Aliment; 2016; 15(2):201-211. PubMed ID: 28071010
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Research Progress in the Relationship between Intestinal Flora and Diabetes Mellitus.
    Lai Y; Huang X; Sun H; Hui Q; Hu S
    Endocr Metab Immune Disord Drug Targets; 2024 Jul; ():. PubMed ID: 38956918
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Crosstalk between intestinal flora and human iron metabolism: the role in metabolic syndrome-related comorbidities and its potential clinical application.
    Yan Y; Zhang W; Wang Y; Yi C; Yu B; Pang X; Li K; Li H; Dai Y
    Microbiol Res; 2024 May; 282():127667. PubMed ID: 38442456
    [TBL] [Abstract][Full Text] [Related]  

  • 31. American Diabetes Association and JDRF Research Symposium: Diabetes and the Microbiome.
    Semenkovich CF; Danska J; Darsow T; Dunne JL; Huttenhower C; Insel RA; McElvaine AT; Ratner RE; Shuldiner AR; Blaser MJ
    Diabetes; 2015 Dec; 64(12):3967-77. PubMed ID: 26420863
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gut Microbiota as a Therapeutic Target for Metabolic Disorders.
    Okubo H; Nakatsu Y; Kushiyama A; Yamamotoya T; Matsunaga Y; Inoue MK; Fujishiro M; Sakoda H; Ohno H; Yoneda M; Ono H; Asano T
    Curr Med Chem; 2018; 25(9):984-1001. PubMed ID: 28990516
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Composition of intestinal flora affects the risk relationship between Alzheimer's disease/Parkinson's disease and cancer.
    Hang Z; Lei T; Zeng Z; Cai S; Bi W; Du H
    Biomed Pharmacother; 2022 Jan; 145():112343. PubMed ID: 34864312
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insights into the role of the microbiome in obesity and type 2 diabetes.
    Hartstra AV; Bouter KE; Bäckhed F; Nieuwdorp M
    Diabetes Care; 2015 Jan; 38(1):159-65. PubMed ID: 25538312
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Diabetes mellitus and the intestinal microbiome].
    Tomasics G; Schandl L; Polyák A; Winkler G
    Orv Hetil; 2023 Jun; 164(25):981-987. PubMed ID: 37356017
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The intestinal microbiome and metabolic diseases : From obesity to diabetes and nonalcoholic steatohepatitis].
    Bischoff SC
    Internist (Berl); 2017 May; 58(5):441-448. PubMed ID: 28432400
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The role of gut microbiota in the pathogenesis of obesity and diabetes].
    Stachowicz N; Kiersztan A
    Postepy Hig Med Dosw (Online); 2013 Apr; 67():288-303. PubMed ID: 23619228
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characteristics of the intestinal flora in patients with peripheral neuropathy associated with type 2 diabetes.
    Wang Y; Ye X; Ding D; Lu Y
    J Int Med Res; 2020 Sep; 48(9):300060520936806. PubMed ID: 32938282
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of natural products and intestinal flora on type 2 diabetes mellitus treatment.
    Aydin OC; Aydın S; Barun S
    World J Clin Cases; 2023 Jan; 11(1):65-72. PubMed ID: 36687192
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Fecal microbiota transplantation regulates the cholinergic anti-inflammatory pathway in cerebral cortex of septic rats through intestinal microbiota].
    Li S; Xu N; Hua R; Niu X; Lyu C; Li M; Li J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Sep; 31(9):1102-1107. PubMed ID: 31657333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.